ISPE: Meetings

17th International Conference on Pharmacoepidemiology

August 23^th - 26^th, 2001
Sheraton Center
Toronto, Canada

POSTER SESSIONS

Guided Poster Tours Guidelines for Poster Presentations Poster Presentations: Poster Session A: Friday, August 24
Poster Session B: Saturday, August 25
Poster Session C: Sunday, August 26

GUIDED TOURS

For those attendees new to pharmacoepidemiology, new to ISPE, or for first-time meeting participants, you are invited to take a tour of selected posters with an ISPE member. The tours will begin at 7:30am daily and last approximately 20 minutes. The guide will discuss the day's events and highlight ongoing research efforts in this dynamic field through a guided tour of the posters on display that day.

GUIDELINES FOR POSTER PRESENTATIONS

Overview
Poster sessions are designed to give presenters an opportunity to discuss informally their research with colleagues interested in their research. The purpose of the posters is to visually stimulate interest in the research, to present sufficient information for viewers to understand the methods, results, and significance of the research, and to promote conversations and networking among conference participants.

Poster Session Schedule and Set Up

Contributed poster sessions and special poster sessions generally run for one day each as follows:
7:00a.m. to 7:30a.m. SET UP All posters must be up by 7:30a.m.
8:00a.m. to 5:00p.m. OPEN
5:00p.m.to 6:00p.m. TAKE DOWN
ISPE and the hotel will not be responsible for any poster that is left up overnight or is lost or damaged. Please adhere to this schedule.
Presenters are asked to be available at their posters for at least two hours (noon - 2:00 p.m.) to discuss their posters with interested viewers.

Numbering system

Each poster board will be numbered. The poster number is the first number listed (below). Presenters should attach their posters to the board number corresponding to the number assigned to their posters in the final program, which will be distributed at the registration desk. Please note that this number may be different from that shown in the preliminary program.

The abstract number, for use in locating abstracts in the final program and the special issue of Pharmacoepidemiology and Drug Safety that will be distributed at the ICPE, is in brackets [ ] after the title of the paper.

Poster sessions will be moderated. Presenters should be at their poster from 1200 to 1400. There will be a daily judging for the best poster presentations. The first prize poster winners will be invited to keep their posters up through the end of the meeting. The best overall poster presented at the 17th ICPE will be recognized and the author will receive a special award at the Closing Session on August 26, 2001.

Poster Specifications

Posters must be designed to fit a 4-ft. (122 cm) high by 8-ft. (244 cm) wide freestanding, poster board. This board will be the only support device available. Business cards or small leaflet literature for distribution may be inserted in an envelope and affixed to the board.
Posters may be attached to the boards by pushpins or Velcro. Although supplies will be available, each poster presenter is advised to bring their own mounting supplies.
Posters may be prepared as a single poster or as several smaller sections mounted together.
The following format is required for all poster presentations. This guide provides you with the expectations regarding content of your poster under the 5 major headings (Background, Objectives, Methods, Results, Conclusions). Posters that do not meet these specifications will not be displayed.
Background:
One or two sentences that describe the clinical (or other) importance of the study question.
Objectives:
The main objective(s) or study question should be explicitly stated (e.g., "To determine the rate of…"). If study was to test an a priori hypothesis, it should be stated.
Methods:
Should include statements that address:
Design: Basic study design, source population, follow-up; For new analyses of existing data the dataset should be disclosed; statement of criterion standard if study of screening or diagnostic test and any blinding; analysis type (e.g., cost-effectiveness, cost-benefit, etc.) if an economic analysis. Matching and selection of controls, if relevant, should also be included.
Setting: To assist reader in determining the relevance of the findings to their own circumstances, the setting or source population should be described including statements regarding generalizability to a larger or more representative population. This may include eligibility, inclusion/exclusion criteria, and for surveys and follow-up studies should include the number eligible versus the number/proportion remaining in the analysis.
Exposures or interventions: explicit naming of medications or other interventions Main outcome measures: the primary and secondary outcome measurement(s) as determined prior to data collection. If hypothesis was formulated after data collection, this should be stated.
Results:
The main outcomes of the study should be provided and quantified, including confidence intervals and/or other significance tests. If differences are not significant, the clinically important difference sought should be stated and the confidence interval for the difference between the groups should be given. When risk changes or effect sizes are reported, absolute values should be included so that the reader can determine the absolute as well as relative impact of the result. Screening and diagnostic test studies should report sensitivity, specificity, and likelihood ratio and if predictive value or accuracy is given, prevalence or pretest likelihood should be provided.
Conclusions:
Only those conclusions that are directly supported by the reported data should be provided, along with their implications (avoiding speculation and overstatement of findings). Emphasis should be given equally to positive and negative findings of equal scientific merit.
Statement of funding source: a statement of funding sources associated with this research must be provided on each poster.

Suggestions for Posters

Keep text brief. Report only key aspects of each section. It is not advisable to display the entire text from a manuscript. Too much detail detracts from the primary message of the text.
Keep figures simple. Convey only one idea per figure, table, or photograph. Figures from publications, theses, or dissertations normally do not make good visuals. Too much detail detracts from the primary message of the figure.
Text and figures should be readable to someone standing at a distance of six feet. Adjust font and image sizes accordingly. BIG IS BEAUTIFUL, and easy to read.
Photographs should clearly show what you want the audience to see.
Use appropriate blank space between words, sections, and figures.
Use appropriate and compatible colors for fonts, backgrounds, graphics, and matting. White backgrounds generally are best for text.
Simple typefaces are preferable to fancy fonts. Bold type may be effective on headings. Select a clean and simple font and use it consistently throughout the poster. Use both upper and lower case letters, especially in the body of your presentation. Make lettering large enough to read from at least three feet.
Avoid overcrowding.
Arrangement. Design the flow of information from left to right. Use lines, frames, contrasting colors or arrows to call attention to important points.
Color. Use color to attract interest and to dramatize similarities and differences. Emphasis may be lost if more than four colors are used.
Vertical posters will not fit the boards; only horizontal posters are allowed.

Suggestions for Presentations

Rehearse your presentation and memorize points you want to emphasize during the poster session. Know where various points are located on your poster so you can refer to them as you talk with viewers, without turning your back or blocking their view.
You may wish to attach your business card and/or write the hotel (or other) telephone number where you can be reached during the meeting.

POSTER PRESENTATIONS

FRIDAY, AUGUST 24
Poster Session A
Sheraton Hall
Moderator:

Does Physician's Racial Bias Effect Choice of Contraceptive Method Prescribed? [12]
Brownsyne Tucker, Kate L Lapane (United States)
Use of Thiazide Diuretics, Psychotropics and the Risk of Hip Fractures in Elderly People- A Pilot Case-Control Study [14]
Thais BT Braga, Gun Bergsten-Mendes, Djalma C Moreira Filho (Brazil)
Incidence of Factitious Hypoglycemia [21]
Thierry C Trenque, Carole C Frances, Marie-Laure Y Germain, Hervé G Millart (France)
Nitrate Vasodilators and Major Upper Gastrointestinal Bleeding [28]
Judith P Kelly, Bengt-Erik Wiholm, Andras Laszlo, Samuel Shapiro, David W Kaufman (United States)
Effect of Dear Doctor Letters and Labelling Changes on the Codispensing of Cisapride with Its Contraindicated Medications [31]
Lisa B Weatherby, Beth Nordstrom, Daniel Fife, Alexander M Walker (United States)
The Postmarketing Surveillance of Pantoprazole on 11 541 Patients Via Prescription Event Monitoring [34]
Cheryl Key, Lynda Wilton, Saad Shakir (United Kingdom)
Withdrawn
Withdrawn
The Effect on Toxicity of Reducing the Size of Available Acetaminophen Pack Sizes in Scotland [65]
C L Sheen, J F Dillon, D N Bateman, K Simpson, T M MacDonald (United Kingdom)
Prevalence Rates of High Lipoprotein (a) by LDL Cholesterol Levels in the US Adult Population: The Third National Health and Nutrition Examination Survey (NHANES III) [66]
Cristina Varas-Lorenzo, Andrew Maguire (Spain)
Reduction in the Intensity of Abortive Migraine Drug Use during Coumarin Therapy [73]
Hamid Rahimtoola, Toine C Egberts, Henk Buurma, Cees C Tijssen, Hubert G Leufkens (The Netherlands)
Cardiovascular Drug Use and Hospitalizations Attributable to Diabetes Mellitus Type 2 [75]
Joëlle A Erkens, Olaf H Klungel, Ronald P Stolk, José A Spoelstra, Diederick E Grobbee, Hubert GM Leufkens (The Netherlands)
Diabetes Mellitus Type 2 Drives Prescription of Antibiotic Drugs [76]
Joëlle A Erkens, Olaf H Klungel, Ronald P Stolk, Svetlana V Belitser, José A Spoelstra, Diederick E Grobbee, Hubert MG Leufkens (The Netherlands)
Does Hepatitis B Vaccination Increase the Risk of Liver Injury in Women Using Combined Oral Contraceptives? [77]
Bernhard Felsch, Thomas Gräser, Herbert Hoffmann, Wolfgang Schumann (Germany)
Urinary Antispasmodic Use and the Risks of Ventricular Arrhythmia and Sudden Death in Elderly Patients [83]
Philip S Wang, Raisa Levin, Sean Z Zhao, Jerry Avorn (United States)
Effectiveness and Cost-Effectiveness of Azithromycin in the Treatment of Community Acquired Pneumonia and Acute Exacerbation of Chronic Bronchitis [86]
Frédéric Lavoie, Anne-Marie Castilloux, Lucie Blais, Jacques LeLorier (Canada)
The Pharmacovigilance of Valsartan: Results of a Post-Marketing Surveillance Study on 12 881 Patients in England [90]
Pipasha N Biswas, Lynda V Wilton, Saad AW Shakir (United Kingdom)
High Persistence of Statin Use in a Danish Population. Compliance Study 1993-1998 [91]
John Larsen, Morten Andersen, Jakob Kragstrup, Lars F Gram (Denmark)
Prescription and Nonprescription Analgesic Medication Use among the U.S. Adult Population [103]
Ryne Paulose, Rosemarie Hirsch, Charles Dillon, Katalin Losonczy, Michael Cooper, Yeshiam Ostchega (United States)
Glycaemic Control in a Cohort of Type II Diabetics in Italy [107]
Marina Maggini, Stefania Spila Alegiani, Roberto Raschetti, DAI Study Group (Italy)
The Impact of Cholesterol Lowering Agents on Urinary Albumin Excretion [111]
Taco BM Monster, Wilbert MT Janssen, Paul E de Jong, Lolkje TW de Jong-van den Berg (The Netherlands)
Reliability of the General Practice Research Database To Identify Major Medical Events in Chronic Diseases [114]
James D Lewis, Colleen Brensinger, Warren B Bilker, Brian L Strom (United States)
Antipsychotics May Worsen Metabolic Control in Type 2 Diabetes Mellitus [115]
José A Spoelstra, Ronald P Stolk, Olaf H Klungel, Joëlle A Erkens, Hubert GM Leufkens, Diederick E Grobbee (The Netherlands)
Prescription of Anti-Anginal Drugs in Relation to Heart Diagnostic Procedures. A One-Year Population-Based Study of Two Danish Counties [118]
Troels Niemann, Torsten Toftegaard Nielsen, Niels Thorsgaard, Jorgen Lous (Denmark)
Withdrawn
Risk of Irritable Bowel Syndrome among Asthma Patients [124]
Consuelo Huerta, Luis Alberto Garcia Rodriguez, Mary-Ann Wallander, Saga Johansson (Spain, Sweden)
Traditional and Nontraditional Medications: Reasons for Use [128]
David Kaufman, Judith Kelly, Lynn Rosenberg, Allen Mitchell (United States)
Effect of Antihypertensive Drug Classes on Pulse Pressure. Preliminary Results [129]
Alejandro De La Sierra, Anna Muñoz, Maite Artes, Juan S Lopez-Agustina (Spain)
Clinical Audit as a Means of Implementing New National Guidelines for Hypertension [133]
Judith M Mackson, Sheena F O'Riordan, Lynn M Weekes (Australia)
Clinical Audit as a Measure of Prescribing Rates and Antibiotic Selection [135]
Judith M Mackson, Lynn M Weekes, Tai Rotem (Australia)
Influenza-Associated Encephalopathy in Japan, - Subtype of Reye's Syndrome? Possible Association with NSAIDs [136]
Harue Tada, Tetuji Sadaike, Chikuma Hamada, Masanori Fukushima (Japan)
Incidence of Permanent Atrial Fibrillation: A Population-Based Study [138]
Ana Ruigomez, Saga Johansson, Mari-Ann Wallander, Luis Alberto Garcia-Rodriguez (Spain, Sweden)
The Risk of Acute Liver Injury in a Diabetes Population [141]
Luis Alberto Garcia Rodriguez, Consuelo Huerta, Sean Z Zhao, Felix M Arellano (Spain, United States)
Risk of Mortality in a Cohort of Newly Diagnosed Atrial Fibrillation [144]
Ana Ruigomez, Saga Johansson, Mari-Ann Wallander, Luis Alberto Garcia-Rodriguez (Spain, Sweden)
Association between Hormone Replacement Therapy and Irritable Bowel Syndrome [146]
Luis Alberto Garcia-Rodriguez, Ana Ruigomez, Saga Johansson, MariAnn Wallander (Spain, Sweden)
Trends in the Use of Antihistamines Drugs in Spain [147]
Ramona Mateos-Campos, Louisa Myriam Beaulieu-Oriol, Antonio Blazquez-Perez (Spain)
Use of Anti-Asthmatic Drugs by Children: Overtreatment with Inhaled Corticosteroids? [151]
Eric Schirm, Hilde Tobi, Henkjan Gebben, Lolkje TW de Jong - van den Berg (The Netherlands)
The Relative and Population Attributable Risk of Congestive Heart Failure in Elderly Patients Taking NSAIDS [152]
Peter T Donnan, Allan D Struthers, Thomas M MacDonald (United Kingdom)
Cardiac Arrhythmias Associated with the Use of Antihistamine Drugs - A Mass Media Attention Reporting Bias? - [161]
Marie L De Bruin, Eugene P van Puijenbroek, Toine CG Egberts, Arno W Hoes, Hubert GM Leufkens (The Netherlands)
Pattern of Cisapride Use within the Portuguese Population [165]
Ana Paula Martins, Zilda Mendes, Magda N Melo, Miguel V Gomes, Pedro Penedo, Ana C Miranda (Portugal)
Time Trends in Lipid Lowering Drug Use in The Netherlands. Has the Backlog of Candidates for Treatment Been Eliminated? [176]
Aukje K Mantel-Teeuwisse, Olaf H Klungel, WM Monique Verschuren, Arijan Porsius, Anthonius de Boer (The Netherlands)
Discontinuation of Antihypertensive Drug Therapy in the Netherlands [178]
Mitad Sarac, Olaf H Klungel, Ron MC Herings, Hubert GM Leufkens (The Netherlands)
Descriptive Epidemiological Study of Doctor Prescribing for Asthma Therapy in Australia [195]
Nicole L Pratt, Justin J Beilby, John E Marley, Don C Walker, Katherine M Duszynski, Carolyn Rutherford, Peter McManus (Australia)
Pilot Study of Prescription-Event Monitoring in Japan (J-PEM) Comparing Losartan with Other Antihypertensives [196]
Kazuo Samizo, Eri Kawabe, Shiro Hinotsu, Yasuo Ohashi, Kiyoshi Kubota (Japan)
The Costs of Uncontrolled Hypertension - A Preliminary Overview [197]
Nicole L Pratt, Justin J Beilby, John E Marley, Don C Walker, Katherine M Duszynski, Michael Nobes, Reg Waldeck, Kelly Macarounas-Kirchman (Australia)
Drug Use in Pregnancy [200]
Syed R Ahmad, Parivash Nourjah, Anne Trontell (United States)
Risk Factors Associated with Endometrial Cancer [202]
Corinne S de Vries, Susan E Bromley, Tim J Williams, Hilary T Thomas, Richard DT Farmer (United Kingdom)
A Pharmacovigilance Study in 14 397 Patients Using Irbesartan in a General Practice Setting [203]
Cheryl Key, Saad Shakir (United Kingdom)
Consequences of Reference Drug Pricing for Angitensin-Converting Enzyme Inhibitors [204]
Sebastian Schneeweiss, Alexander M Walker, Robert J Glynn, Malcolm Maclure, Dormuth Colin, Stephen B Soumerai (United States, Canada)
An Analysis of Reports of Statin-Associated Rhabdomyolysis Submitted to the Food and Drug Administration [205]
Mohamed A Omar, James P Wilson (United States)
Do Events Reported by Doctors Differ from Those by Pharmacists in Prescription-Event Monitoring in Japan (J-PEM)? [206]
Tsugumichi Sato, Eri Kawabe, Kiyoshi Kubota (Japan)
Prospective Observational Cohort Safety Study To Monitor the Introduction of a Non-CFC Formulation of Salbutamol with HFA134a in England [208]
Patrick M Craig-McFeely, Jane M Riley, Joan B Soriano, William C Maier, Saad AW Shakir (United Kingdom)
Pregnancy Outcomes during the Introduction of Ventolin Evohaler^TM
in England during 1999 [209]
Patrick M Craig-McFeely, Jane M Riley, Joan B Soriano, William C Maier, Saad AW Shakir (United Kingdom)
Predictive Factors of Miglitol Response in the Treatment of Type 2 Diabetes Mellitus [213]
Ricardo García- Mayor, Pedro Benito, Eduardo Faure, José Mesa, Manuel Puig-Domingo, Luis F Pallardo, Juan S López, Maite Artés, Ramón Ravella (Spain)
Validation of Decision Model for Pharmacological Primary Prevention in Post-Menopausal Women [214]
Sylvie Perreault, Carey Levinton, Yola Moride, Louis-Georges Ste-Marie, Claudine Laurier, Ralph Crott, François Bellavance (Canada)
Glucocorticoid Induced Osteoporosis Management in a Rheumatology Practice [215]
Daniel H Solomon, Jonathan Jacobs, Alison LaTourette, Jeffrey N Katz, Jonathan Coblyn (United States, United States)
Efficacy, Tolerability and Discontinuation of Leflunomide in Unselected Outpatients with Rheumatoid Arthritis [231]
Eric N van Roon, Lina A Mourad, Tim LThA Jansen, Petronella M Houtman, George AW Bruyn, Ed N Griep, Jacobus RBJ Brouwers (The Netherlands)
Results of the Flurbiprofen Accelerated Switch Trial (FAST) - The First European Trial of a POM in an OTC Setting [234]
Iain A Gibb, Joseph C Veltri, Brent A Page, Andrew Charlesworth, Kennie-Marie Miller, Helen Shaw, Norma Kellett (United Kingdom, United States)
Study of Willingness To Pay for a Screening Mammogram: Choice of Sample and Question Format [239]
Michelle Savoie, Pierre Ouellette, Jacques LeLorier (Canada)
Risk of Myocardial Infarction and Cardiac Death among Users of Non-Steroidal Anti-Inflammatory Medications [241]
Priscilla Velentgas, Clorinda Cali, Nancy A Dreyer, Alexander M Walker, Kenneth M Verburg (United States)
Nested Case-Control Study on the Association between Histamine-2-Receptor Antagonist and Gastric Cancer in the Korean Elderly [247]
Yooni Kim, Seung-Mi Lee, Kyoung-Eun Yoon, Dae-Seog Heo, Kui-Oak Jung, Ji-Eun Paek, Byung-Joo Park (Republic of Korea)
A Comparison of the Cost Implications of Using Ramipril and Perindopril for the Secondary Prevention of Stroke; A Case Study Using the General Practice Research Database [249]
Stephen R Chapman (United Kingdom)
Switching of Nonsteroidal Anti-Inflammatory Agents (NSAID) into Self Care - Impact on Their Consumption and Cost in Finland [253]
Tinna J Voipio, Pirkko K Paakkari, Esko J Nuotto (Finland)
The Safety of the Leukotriene-Receptor Antagonists, Montelukast [255]
Pipasha Biswas, Lynda V Wilton, Gillian L Pearce, Shayne S Freemantle, Saad AW Shakir, Ronald D Mann (United Kingdom)
Use of COX-2 Inhibitors in Italy: Shifting from Traditional NSAIDs and Concomitant Prescription of Gastroprotective Agents among Users [256]
Giuseppe Traversa, Clara Bianchi, Francesca Pisetzky, Mariangela Rossi (Italy)
Access to Medicines in Pregnancy and Infants [257]
Irina Kazarian, Lusine Vardanyan, Aida Djangirova (Armenia)
Profile of Patients Treated with Aspirin in Primary Care [258]
Imma Ferreres, Gloria Pueyo, Montse Martínez, Esther Barnés, Juan Salvador López, Maite Artés, Montse Pérez (Spain)
Angiotensin-Converting Enzyme Inhibitors and Risk of Cancer - A Population-Based Cohort Study in Denmark [260]
Søren Friis, Henrik T Sørensen, Lene Mellemkjaer, Joseph K McLaughlin, Gunnar L Nielsen, William J Blot, Jørgen H Olsen (Denmark, United States)
Tolerability of Miglitol in the Treatment of Type 2 Diabetes Mellitus. Final Results after 12 Months of Follow-Up [261]
José Mesa, Eduardo Faure, Ricardo García-Mayor, Pedro Benito, Luis F Pallardo, Manuel Puig-Domingo, Maite Artés, Juan S Lópea, Ramón Ravella (Spain)
Effectivity and Safety of Ibuprofen Retard in Chronic and Acute Processes [263]
Alfons Mirada, Juan Salvador López (Spain)
Preparing Administrative Claims Data for Evaluation of Limited Use Criteria [274]
Colleen J Metge, Marina Yogendran (Canada, Canada)
Acceptability of Outcome Research Studies by Community Pharmacists in France [280]
Eric Van Ganse, Nicholas Moore, Genevieve Chamba, Gabrielle Ziegler, Guilhem Pietri, Laurent Laforest (France, Switzerland)
Recent Patterns of Asthma Medication Use among Pregnant Women [300]
Carol Louik, Sonia Hernandez-Diaz, Michael Schatz, Allen A Mitchell (United States)
Utilization of Antiretrovirals by HIV Outpatients in Ontario, Canada [303]
Michelle D Furler, Thomas R Einarson, Reina Bendayan (Canada)
Risk of Asthma Exacerbations Associated with Allergic Rhinitis [307]
Jordi Castellsague, Luis Alberto Garcia-Rodriguez, Ana Rueda, Andrew Maguire (Spain)
Using Retrospective Claims Data To Design Clinical Safety Surveillance of Thiazolidinedione Drugs [309]
Caroline M Henriques, Daniel Schultz, Tracy L Milanette, Karen Todoroff, Micheline Kim (United States)
Use of Acetaminophen among Patients Hospitalised for Exacerbations of Obstructive Lung Diseases [315]
Charles MJM Gerrits, Ron MC Herings, Hubert GM Leukens, Jan-Willem J Lammers (The Netherlands)
The Risk of Disseminated Intravascular Coagulopathy (DIC) among Maternal Deliveries Induced by Two Labor Induction Agents, Dinoprostone Cervical Gel (DCG), and Dinoprostone Vaginal Insert (DVI) [320]
Sean Z Zhao, Matthew W Reynolds, Felix M Arellano (United States)
Adverse Pregnancy Outcomes Associated with Maternal Enalapril Antihypertensive Treatment [321]
Sonia Tabacova, Yi Tsong, Carole A Kimmel (United States)
Prevalence and Resource Utilization of Viral Hepatitis Infection in Taiwan in 1998 Based on the National Health Insurance Research Database: A Pilot Study [325]
K Arnold Chan, Daniel M Rosenberg, Jia-Horng Kao, Jasmine Pwu, Suzanne F Cook, Ding-Shinn Chen (United States, United Kingdom, Taiwan)
A Decade of Antiarthritic Use in Canada: A Descriptive Analysis of Utilization and Expenditures [327]
Stacey S Carpenter, Michiel EH Hemels, Thomas R Einarson (Canada)
A Pharmacoeconomic Model of Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine and Clopidogrel [332]
Dennis W Raisch, Crystal L Harris, Glenn Ramsey, Mark E Brecher, Nick Bandarenko, Charles L Bennett (United States)
Pharmaceuticals and Satellites: Exploring for Environment Precursors of Asthma Attacks [337]
Sheila R Weiss, Daniel S Kimes, Elissa Levine, Monica Myers, Mary E Bollinger, Carol J Blaisdell (United States)
Evaluation of the Incidence of Angioneurotic Oedema Occurring on Antihypertensive Drugs - A Comparative Prescription-Event Monitoring Study [339]
Nayan V Acharya, Saad AW Shakir (United Kingdom)
Relative Risk of Heart Failure among Non-Steroidal Anti-Inflammatory Drug Users [344]
Luis A García-Rodríguez, Sonia Hernández-Díaz (Spain, United States)
A Comprehensive Database on the Use of Medications and Medical Services during Pregnancy among Women with Pre-Existing Chronic Conditions: A Pilot Study [349]
Marie-Claude Martel, Yola Moride, Lise Gauthier, Christine Cadrin, Jean-Pierre Grégoire (Canada)
Does Use of Statins Spare Bone in Older Men? [363]
Donald R Miller, Elizabeth Krall, Jennifer J Anderson, Sharon Rich, Amy Rourke (United States)
Analysis of a Cohort of Patients with Advanced Rheumatoid Arthritis Using a Practice Based Pharmacoepidemiologic Database [373]
Brian D Hanna, Michael Iskedjian, Stacey Carpenter, Thomas R Einarson, Andreas Maetzel, Heather Bennett (Canada)
A Medication-Based Index for Defining Asthma Severity in Population Health Research [378]
Wendy J Ungar, Kenneth R Chapman, Maria T Santos (Canada)

SATURDAY, AUGUST 25
Poster Session B
Sheraton Hall
Moderator:

Neuropsychiatric Changes and Concentration Impairment during the Prophylactic Use of Mefloquine [4]
Melanie M van Riemsdijk, Anne-Marie Ditters, Miriam CJM Sturkenboom, Joke HM Tulen, Robert J Ligthelm, David Overbosch, Bruno HCh Stricker (The Netherlands)
Efficacy of Angiotensin II Receptor Antagonists in Preventing Headache: Systematic Overview and Meta-Regression Analysis [6]
Mahyar Etminan, George Tomlinson, Mitchell A Levine, Paula A Rochon (Canada)
Predictors of Under-Use of Antibiotics for Urinary Tract Infections in Emergency Departments [11]
Anick Berard, Polly E Bijur, E John Gallagher (United States)
The Effect of a Triplicate Benzodiazepine Prescribing Policy on the Use of Benzodiazpines in a Nursing Home Population [13]
Anne M VanHaaren, Kate L Lapane, Carmel M Hughes (United States, United Kingdom)
Prescription Event Monitoring of Quetiapine: An Atypical Anti-Psychotic [22]
Cheryl Key, Saad Shakir (United Kingdom)
Economic Impact on a Hospital of an Antibiotic Sequential Therapy [24]
I Escobar, A Pablos, JM Ferrari, A Herreros de Tejada (Spain)
Multicentre Evaluation of Prescribing Concurrence with Regional Anti-Infective Guidelines [32]
Roel Fijn, Man-Chie Chow, Pauline Schuur, Koos Brouwers, Lolkje de Jong-van den Berg (The Netherlands)
A National Survey of Antimicrobial Prophylaxis in Adult Cardiac Surgery across Canada [33]
Fran L Paradiso-Hardy, Patti Cornish, Chantal Pharand, Stephen E Fremes (Canada)
Is There an Association between Selective Serotonin Reuptake Inhibitors and Risk of Abnormal Bleeding? Results from a Cohort Study Based on Prescription Event Monitoring in England [38]
Deborah Layton, David WJ Clark, Saad AW Shakir (United Kingdom, New Zealand)
The Safety and Effectiveness of Newer Anti-Epileptics: A Comparative Post-Marketing Cohort Study [39]
Nayan V Acharya, Ruth M Pickering, Lynda V Wilton, Saad AW Shakir (United Kingdom)
Appropriateness of Antibiotic Use in a University Hospital [45]
Marcia RCC Fonseca, Thais BT Braga, Plinio Trabasso, Gun B Bergsten-Mendes (Brazil)
Reports of Withdrawal Syndrome with the Use of SSRI's : A Case/Non Case Study in the French Pharmacovigilance Data Base [46]
Thierry C Trenque, Dorothée Y Piednoir, Carole C Frances, Marie-Laure Y Germain (France)
Overuse of Antibiotics for the Common Cold and Upper Respiratory Tract Infections in Emergency Departments: Results from a National Study [48]
Anick Berard, Polly E Bijur, E John Gallagher (United States)
Risk Factors for Neuropsychiatric Adverse Events during the Prophylactic Use of Mefloquine [51]
Melanie M van Riemsdijk, Miriam CJM Sturkenboom, Anne-Marie Ditters, Joke HM Tulen, Robert J Ligthelm, David Overbosch, Bruno HCh Stricker (The Netherlands)
Neuropsychiatric Adverse Events Are Associated with Increased Serum Levels of Mefloquine [52]
Melanie M van Riemsdijk, Miriam CJM Sturkenboom, Anne-Marie Ditters, Robert J Ligthelm, David Overbosch, Chris J van Boxtel, Bruno HCh Stricker (The Netherlands)
Atovaquone Plus Proguanil vs Mefloquine for Malaria Prophylaxis - A Focus on Neuropsychiatric Adverse Events [53]
Melanie M van Riemsdijk, Miriam CJM Sturkenboom, Anne-Marie Ditters, Robert J Ligthelm, David Overbosch, Bruno HCh Stricker (The Netherlands)
Hepatic and Cardiovascular Events Following Use of Quinolone Antibiotics in Cohorts from the Drug Safety Research Unit Prescription-Event Monitoring Database [54]
David WJ Clark, Deborah Layton, Lynda V Wilton, Gillian L Pearce, Saad AW Shakir (United Kingdom, New Zealand)
Is There a Link between the Anticholinergic Drug Tolterodine and Psychiatric Events? Results from a Cohort Study Based on Prescription Event Monitoring in England [56]
Deborah Layton, Saad AW Shakir (United Kingdom)
Start of Antipsychotic Drugs in New Patients with Parkinson's Disease [57]
David AMC van de Vijver, Raymund AC Roos, Paul AF Jansen, Arijan J Porsius, Ton de Boer (The Netherlands)
Withdrawn
Influence of Benzodiazepines on Antiparkinsonian Drug Treatment in Patients with Parkinson's Disease [60]
David AMC van de Vijver, Raymund AC Roos, Paul AF Jansen, Arijan J Porsius, Anthonius de Boer (The Netherlands)
Antibiotic Utilisation at Hospitals in Montenegro [61]
Yolanda Barbera-Laínez, Enrique Soler-Company, Natasa Novakovic, Carmen Montaner-Abasolo (Montenegro, Spain)
Results of a Postal Survey of Non Responders in a Prescription Event Monitoring Study [72]
Cheryl Key, Saad Shakir (United Kingdom)
Isotretinoin and Psychiatric Disorders [79]
Robert C Nelson (United States)
Trends in Methylphenidate and Dexamphetamine Prescribing in Nova Scotia, Canada [80]
Christiane Poulin, Ingrid Sketris, Kevin Gordon (Canada)
Prescription Behaviour of Doctors Regarding Dosage Recommendations [81]
Detlef Schröder-Bernhardi, Gerhard Dietlein (Germany)
Behavioral Problems and Off-Label Use of Donepezil in the Nursing Home [87]
Claudio Pedone, Kate L Lapane (United States, Italy)
Costs of Medical Resources Utilisation in Quebec Schizophrenic Patients Users of Olanzapine or Risperidone [98]
Anne-Marie Castilloux, Michelle Savoie, Jacques LeLorier (Canada)
Multivariate Meta-Analysis of Controlled Drug Studies for Obsessive-Compulsive Disorder [109]
Deborah L Ackerman, Sander Greenland (United States)
The Influence of Social and Family Factors on the Prescription of Antibiotics in 0 to 2-Year-Old Children [113]
Nana Thrane, Henrik C Schønheyder, Charlotte Olesen, Henrik T Sørensen (Denmark)
The Use of Proportional Reporting Ratios for Signal Generation in Prescription Event-Monitoring [120]
Emma L Heeley, Lynda V Wilton, Saad AW Shakir (United Kingdom)
Levofloxacin and Newer Macrolides in Community-Acquired Pneumonia: A Statistical Meta-Analysis [121]
Michael P Jones, Ivan T Shaw, Simon Ferrazzi, Andrew Eggleston (Australia, Canada)
Evaluation of a Multifaceted National Program to Improve Prescribing - The Antibiotics Program [126]
Jenny Bowman, Judith M Mackson, Lynn M Weekes (Australia)
Risk of Serious Blood Dyscrasia in Users of Antibiotics [139]
Consuelo Huerta, Luis Alberto Garcia Rodriguez, Sean Z Zhao, Felix M Arellano (Spain)
Estimation of French Epilepsy Prevalence Rate from Drug Sales Data [142]
Stephanie Lefebvre, Jean-Pierre Daures, Francis Sartor, Denise Walckiers, Abdelkader El Hasnaoui (France, Belgium, France)
The Risk of Acute Liver Injury in a Parkinson Population [143]
Luis Alberto Garcia Rodriguez, Consuelo Huerta, Sean Z Zhao, Felix M Arellano (Spain, United States)
Observational Follow-Up Study of a Cohort of Antipsychotic Users: Are There Sexdifferences in Comedication in First-Psychosis? [148]
Claudia AW Rijcken, Hendrikus Knegtering, Richard Bruggeman, Lolkje TW De Jong-Van den Berg (The Netherlands)
Antibiotic Use and the Risk of Cerebrovascular Disease in Elderly Subjects Treated for Hypertension [150]
Paul Brassard, Chantal Bourgault, James Brophy, Abbas Kezouh, Samy Suissa (Canada, United States)
Utilization Trends of Antidepressants in Canada over the past Two Decades: A Descriptive Analysis [155]
Michiel EH Hemels, Maarten J ten Berg, Thomas R Einarson (Canada, The Netherlands)
Predictors of Antiviral Treatment for Influenza, 1999-2000 Season [166]
Jeanne E Loughlin, J Alexander Cole, Daniel Rosenberg, Suzanne Cook, Alexander M Walker (United States, United Kingdom)
Risk of Liver Failure in Association with Antifungal Drugs for Onychomycosis [167]
Syed R Ahmad, Anne Trontell, Marilyn Pitts, Claudia Karwoski, Julie Beitz (United States)
Fluoroquinolones and Risk of Liver Injuries: Comparison of Trovafloxacin, Ciprofloxacin and Levofloxacin [170]
Suellen M Curkendall, Judith K Jones, Gretchen Dieck, Earl Goehring, Dewei She, Jingping Mo (United States)
Comparative Study of Mortality Rates and Cardiac Arrhythmias in Post-Marketing Surveillance Studies of Sertindole and Two Other Atypical Antipsychotic Drugs [172]
Lynda V Wilton, Emma L Heeley, Ruth M Pickering, Saad A Shakir (United Kingdom)
A Descriptive Study of the Prescribing of Psychotropic Medications among Children Aged 18-Years and Younger in the United States [174]
Tongtong Wang, Boji Huang, Kenneth A Bachmann (United States)
Prevalence of Antibiotic Resistant E. coli in Feces among Unselected Patients of General Practitioners in Germany [183]
Hermann Brenner, Til Sturmer, Andrea Erb, Cuneyt Gundogan, Hans-Peter Zeitler, Reinhard Marre (Germany)
Determinants of Antibiotic Resistance in Fecal E. coli in Patients of General Practitioners in Southwest Germany [184]
Til Sturmer, Andrea Erb, Hans-Peter Zeitler, Cuneyt Gundogan, Reinhard Marre, Hermann Brenner (Germany)
Spontaneous Lapses in Dosing during Chronic Treatment with Antidepressant Drugs [186]
Welmoed EE Meijer, Marcel L Bouvy, Eibert R Heerdink, John Urquhart, Hubert GM Leufkens (The Netherlands)
Predicting Continuing Benzodiazepine (BZD) Use [188]
C Ineke Neutel, Wikke Walop, Scott B Patten (Canada)
Transfer of Selective Serotonine Reuptake Inhibitors (SSRIs) in Breast Milk of Women with Post Partum Depressions [190]
Hedvig M Nordeng, Erik Bøhler, Yngvild K Bergsholm, Olav Spiget (Norway)
Underreporting of Adverse Drug Reactions (ADRs) in Elderly Patients Using SSRIs? [191]
Welmoed EE Meijer, Eibert R Heerdink, Jacques ThM van Eijk, Hubert GM Leufkens (The Netherlands)
Does Therapeutic Indications of Antidepressants Change from One Year to Another? [210]
Emilio J Sanz, Carlos De las Cuevas, Juan De la Fuente (Spain)
Recent Trends in the Use of Antidepressant Drugs in Australia, 1990-1998 [220]
Peter McManus, Andrea Mant, Philip B Mitchell, William S Montgomery, John E Marley, Merran E Auland (Australia)
Effectiveness of Bupropion [224]
Marcel L Bouvy, Henk Buurma, Toine C Egberts (The Netherlands)
On Technical Methods of Signal Generation and Some Applications [230]
Bharat T Thakrar, Karen S Blesch, Susan T Sacks (Switzerland)
Taking a Look at CNS Stimulant Use in Quebec Children Since 1995 [235]
Louise Barnard, Nancy Lajeunesse (Canada)
Prescriptions for Psychotropics and Anorectics by Medical Specialty in the City of Campo Grande, MS, Brazil, in 1999 [244]
Fernando C Ferreira, Gilberto V Cerquetani, Maria L Oshiro, Lia LC Castro (Brazil)
Nested Case-Control Study on the Association between Alcohol and the Risk of Proximal Hip Fracture in the Elderly People in Korea [246]
Kui-Oak Jung, Hye-Won Koo, Jong-Myon Bae, Byung-Joo Park (Republic of Korea)
Backward Approach for Estimating Physician-Specific Diagnostic Test Characteristics: A Unified Approach in Analytical Epidemiology and Clinical Epidemiology [250]
Shai Linn, Noam Hai, Yaron Harsi (Israel)
Delay of Antipsychotic Treatment Leads to Seclusion in Psychiatric Inpatients [251]
Joost J Stolker, Gerard WK Hugenholtz, Eibert R Heerdink, Henk LI Nijman, Hubert GM Leufkens, Willem A Nolen (The Netherlands)
Utilization of Antibiotics in a University Teaching Hospital [252]
Alexandre V Bedenkov, Alla S Andreeva, Dmitry V Galkin, Leonid S Stratchounski (Russian Federation)
Prior Antibiotic Use and the Occurrence of Antibiotic Resistant E. coli in Feces in the German General Population [254]
Andrea Erb, Til Sturmer, Hermann Brenner, Reinhard Marre (Germany)
Application of Multilevel Modelling to Benefit Risk Assessment in Pharmacovigilance Data [265]
Rajnikant L Mehta, C Cirlan-Sevoz (United Kingdom)
Tolerability and Effectivity of Itraconazole in the Treatment of Micosis [268]
Juan S López, Alfons Mirada, Maite Artés (Spain)
Hospitalization Costs Associated with Antidepressant Therapy in Depressed Patients with or without Anxiety [269]
William H Crown, George J Wan, Ernst R Berndt, Stan N Finkelstein, Davina Ling (United States)
Channeling of Atypical Antipsychotics to Patients Not Responding Satisfactorily to Classical Antipsychotics [271]
Nancy S Breekveldt-Postma, Igor ERM Schillevoort, Martien JM Panneman, Willem A Nolen, Ron MC Herings (The Netherlands)
Prevalence of Psychoactive and Anti-Epileptic Drugs Consumption by Children in the Netherlands [272]
Jacqueline G Hugtenburg, Irmgard Themen, Eibert R Heerdink (The Netherlands)
Mortality during Use of Sertindole and Other Anti-Psychotics in the Netherlands and Belgium [273]
Miriam CJM Sturkenboom, Gino Picelli, Nicholas Moore (The Netherlands, Italy, France)
Myocarditis and Cardiomyopathy Associated with Clozapine: The US Experience [275]
Lois La Grenade, David J Graham, Anne Trontell (United States)
Initial Antipsychotic Treatment in Hospitalised Psychiatric Patients [279]
Gerard WK Hugenholtz, Joost J Stolker, Eibert R Heerdink, Willem A Nolen, Hubert GM Leufkens (The Netherlands)
Nocturnal Hospital Admission for Accidental Falls Associated with the Use of Short Half-Life Benzodiazepines and Polyuria [283]
Ron MC Herings, Bruno HCh Stricker (The Netherlands)
Community Acquired Pneumonia (CAP): Is Hospitalization Really Need? [289]
Francesca Gasbarri, Veronica Scurti, Marilena Romero, Antonella Pedrini (Italy)
A Three-Year Trend for the Prescription of Psychotropic Agents to Children Aged 18 Years or Younger in the United States: An Analysis of the National Ambulatory Medical Care Survey from 1996-1998 [292]
Boji Huang, Tongtong Wang, Kenneth A Bachmann, Randi Chen, Jennifer L McAllister (United States)
Antiepileptics and Liver, Testes, Cervix Uteri and Vulvar Cancer: A Cohort Study [301]
Alejandro Arana, Lia Gutiérrez, Susana Pérez-Guthann, Luis Alberto García-Rodríguez (Spain, Spain)
Relationship between Advertising Expenditures and Sales of Antidepressant Drugs in Canada: A Longitudinal Study [308]
Maarten J ten Berg, Michiel EH Hemels, Thomas R Einarson (The Netherlands, Canada)
Historical Changes in Pharmacological Treatment Options for Depression: A Descriptive Analysis for Canada [313]
Michiel EH Hemels, Thomas R Einarson (Canada)
Sparse-Data Bias in Pharmacoepidemiology: The Hemorrhagic Stroke Project (HSP) Case-Control Study on PPA and Risk of Hemorrhagic Stroke (HS) [314]
Parivash Nourjah, Anne Trontell, Yi Tsong, Lois La Grenade, David Graham, Julie Beitz (United States)
Adverse Events Reported with Cosmetic Use of Botulinum Toxin A [316]
Sharon K Gershon, Robert P Wise, M Miles Braun (United States)
Recruiting Community Based Physicians and Pharmacists: Lessons Learned in the ABX Study [323]
Paul M Peloso, Yvonne Shevchuk, Karen Jensen, Joe M Blondeau, Dean Bradley, Loren Regier, The ABx Study Group (United States, Canada)
Extrapyramidal Syndromes Associated with SSRI-Use [328]
Igor Schillevoort, Eugene P Van Puijenbroek, Anthonius De Boer, Raymund AC Roos, Paul AF Jansen, Hubert GM Leufkens (The Netherlands)
The Brighton Collaboration: An International Collaborative Effort To Enhance Comparability of Vaccine Safety Data [330]
Katrin S Kohl, Jan Bonhoeffer, Robert Chen, Harald Heijbel, Ulrich Heininger, Thomas Jefferson, Elisabeth Loupi (United States, Switzerland, Sweden, United Kingdom, France)
Clinical Immunization Safety Assessment Centers: Enhancing Vaccine Safety Surveillance along with Patient Care [334]
Robert P Pless, Robert T Chen (United States)
Mortality and Cardiovascular Morbidity among Patients with Schizophrenia [335]
Cheryl L Enger, Lisa Weatherby, Robert F Reynolds, Dale Glasser, Alexander M Walker (United States)
Pain in a Very Old Population [336]
Maria Stella T Giron, Yvonne Forsell, Cecilia Bernsten, Mats Thorslund, Bengt Winblad, Johan Fastbom (Sweden)
Reporting Trends of Hypersensitivity Reactions in VAERS Following Live Virus Vaccines Containing Gelatin [343]
Vitali Pool, Robert P Pless, Robert T Chen (United States)
Evaluation of a Modified Brief Pain Inventory to Measure Pain Associated with Herpes Zoster [348]
Paul Coplan, Ken Schmader, Alexander Nikas, Ivan Chan, Peter Choo, Harry Guess, Myron Levin, Gary Johnson, Michael Oxman (United States)
Utilization Pattern of Systemic Antiinfectives in a Teaching Hospital in Sari, Iran [351]
Faranak Ansari, Ahamad Ramezani, Mohammad EbrahimZade (Islamic Republic of Iran)
Contribution to the Improvement of Pharmacy Services in the Municipality of Campo Grande, Mato Grosso do Sul State, Brazil [352]
Maria EA Ajalla, Lia LC Castro (Brazil)
The Validity of a Measure of the Severity and Duration of Herpes Zoster Pain [355]
Paul Coplan, Ivan Chan, Ken Schmader, Alexander Nikas, Peter Choo, Harry Guess, Myron Levin, Gary Johnson, Michael Oxman (United States)
Thioridazine: CIOMS IV Risk Benefit Assessment Using Proportional Reporting Ratios and All Available Evidence [359]
J Moseley, S Wark, A Horsfall, P Arlett (United Kingdom)
Physician Satisfaction with Academic Detailing and Individualized Audit and Feedback [367]
Paul M Peloso, Yvonne Shevchuk, Karen Jensen, Loren Regier, Dean Bradley, Joe Blondeau, The ABx Study Group (United States, Canada)
Proportional Reporting Ratio Calculations from a Pharmaceutical Company Database [370]
Jean Kilgour-Christie, Andrzej Czarnecki, Valerie Simmons ()
Benzodiazepine Utilization Patterns in Alzheimer's Disease Patients [372]
Rajaa Lagnaoui, Nicholas Moore, Yola Moride, Ghada Miremont-Salamé, Bernard Bégaud (France, Canada)
Use of Diazepam in Pregnant Women and Their Possible Effects on the Fetus and the Newborn [375]
Lilian Dyce Gordon, Elisa Dyce Gordon, Yanile Ariz Olmo, Beatriz Dyce Gordon, Guillermo Pardo Cardoso (Cuba)
Treating Community Acquired Pneumonia in Ambulatory Patients - Evidence-Based Treatment or Educated Guesswork? [377]
L M Bierre, M M Kochen, Theo Verheij (Germany, The Netherlands)
Pattern Recognition Using a Recurrent Neural Network and Its Application to the WHO Database [380]
Andrew Bate, Roland Orre, Marie Lindquist, I R Edwards (Sweden)

SUNDAY, AUGUST 26
Poster Session C
Sheraton Hall
Moderator:

Can ICD-9 Codes Be Used as a Proxy for Disease Staging in Economic Evaluations? [10]
Simu K Thomas, Sandra E Brooks, C Daniel Mullins (United States)
Relation between Unemployed and Drug Utilization.Argentina 1990-1999 [19]
Ricardo Bolaños, Claudio D González, Rodolfo Chaij, Jimena Worcel, Luis E Nudelman, Ines Bignone, Estela R Giménez (Argentina)
Control, Violators, Inclusion Citeria and Redefining the Pragmatic Trial [35]
Alex D McMahon (United Kingdom)
Reporting Pattern of Adverse Drug Reactions to the Committee on Safety of Medicines in PEM Studies [36]
Emma L Heeley, Jane Riley, Lynda V Wilton, Saad A Shakir (United Kingdom)
Lipid Data Collection Practices in U.S. Renal Transplant Centers [63]
Mei-Sheng Duh, Elena Rivero, Cristina Varas, Donnie Funch, Priscilla Velentgas, Alexander M Walker (United States, Spain)
Co- and Multimedication in ASA- and Tocopherol-Users in Germany -Results of the Federal-Health-Surveys [64]
Hans-Ulrich Melchert, Hildtraud Knopf, Ellen Pabel, Yong Du (Germany, China)
"Quantitative and Qualitative Tracking of Patients"-An Integrative Method of Getting Insight of Doctors' and Patients' Behaviour [67]
Michael Elosge, Gerhard Dietlein (Germany)
Adverse Drug Reactions Due to Medication Errors: Case Series from a Spontaneous Reporting Scheme [69]
Katharina Hartmann, Max Kuhn (Switzerland)
Incidence and Preventability of Adverse Drug Events in Ambulatory Geriatric Patients [71]
Jerry Gurwitz, Terry Field, Leslie Harrold, Jeffrey Rothschild, Kristin Debellis, Andrew Seger, Cynthia Cadoret, Leslie Fish, Lawrence Garber, Jackie Cernieux, David Bates (United States)
A Comparison of Two Commercial Products for Facilitating Use of the FDA SRS/AERS Databases [78]
Karen S Blesch, Bharat Thakrar, Susan T Sacks (United States, Switzerland)
Spontaneous Reporting of Adverse Drug Reactions: Estimation of Under-Reporting for Contrast Media Reactions in 14 Countries [89]
Alexander Michel, Abudulai Alhassan, Wolfgang Schumann (Germany)
Medical Device Surveillance: Swan-Ganz Catheters [92]
Ronald G Kaczmarek, Chih-Hsin K Liu, Thomas P Gross, Wolf Sapirstein, Brad C Astor (United States)
Drug Interactions Contribute Moderately to Overanticoagulation on Phenprocoumon or Acenocoumarol [96]
Fernie JA Penning-van Beest, Erik van Meegen, Frits R Rosendaal, Bruno HCh Stricker (The Netherlands)
Recent Incidence and Case Characteristics of Post Transplant Lymphoproliferative Disorder (PTLD) among Renal Transplant Patients in the U.S. [99]
Donnie P Funch, Joanne Brady, Hnin Hnin Ko, Kathleen M Shea, Alexander M Walker (United States)
Drug Benefit Plans under Managed Care: To What Extent Do Elderly Subscribers Selecting Less Drug Coverage Put Themselves at Increased Financial Responsibility? [100]
Susan E Andrade, Jerry H Gurwitz (United States)
Time Required and Human Resources Available for Approval of New Drugs in Canada, Australia, Sweden, the UK and the US in 1992-98 [101]
Nigel SB Rawson (Canada)
A Novel Method for Detecting Potential Drug-Drug Interactions Using Post-Marketing Adverse Event Database [102]
Kenneth C Kwong, Josh Sammon, Kenneth Hornbuckle, Man C Fung, Isaac W Hammond, James Kotsanos (United States)
A Study of Product Labeling - A Retrospective Analysis of the Content of Product Labeling of Prescription Drugs with the Risk of Hepatic Failure [104]
Mary E Willy, Zili Li (United States)
Pediatric Inpatient Drug Exposures: Results of Two Pilot Studies of Eleven Selected Drugs [106]
Carolyn A McCloskey, Judy A Staffa (United States)
Practice of Herbal Counseling of Community Pharmacists in Thailand [112]
Arthorn Riewpaiboon, Nalin Janewitvichaikul, Petcharat Pongcharoensuk (Thailand)
Key Events Experienced by Sildenafil Users in England - A Non-Interventional Cohort Study [125]
Andrew J Boshier, Lynda V Wilton, Saad A Shakir (United Kingdom)
Assessing the Occurrence and Preventability of Prescribing Potentially Hazardous/Contraindicated Drug Combinations in General (Family) Practice [130]
Yen-Fu Chen, Anthony J Avery, Karen Neil, Christine Johnson (United Kingdom)
Publication Frequency of Research Presented at the ICPE 1999 Meeting [163]
Toine C Egberts, Hubert G Leufkens (The Netherlands)
The Italian National Drug Use Monitoring Center [164]
Pietro Panei, Antonio Addis, Massimo Brunetti, Bruno Caffari, Roberto Da Cas, Nicola Magrini, Angelo Menna, Francesca Ravaioli, Francesca Tosolini, Giuseppe Traversa, Roberto Raschetti (Italy)
Topical Corticosteroid Utilization in Seniors in Nova Scotia [189]
Charmaine A Cooke, Ingrid S Sketris, Pam R McLean-Veysey, Dawn M Frail (Canada)
Knowledge and Attitudes to Adverse Drug Reaction Reporting of Community Pharmacists in the Netherlands [194]
Kees van Grootheest, Kyros Mes, Eugene P van Puijenbroek, Lolkje TW de Jong - van den Berg (The Netherlands)
Drug Use in Urban and Rural Populations of the Oldest Old [198]
Inga Klarin, Johan Fastbom, Anders Wimo (Sweden)
Determinants of Sildenafil Discontinuation in the Dutch Cohort of Sildenafil Users [211]
Patrick C Souverein, Toine C Egberts, Miriam CJM Sturkenboom, Eric J Meuleman, Hubert GM Leufkens, John Urquhart (The Netherlands)
Description of the Continuity of Appropriate Drug Use from Hospital to Home in Elderly [217]
Sylvie Perreault, Louise Ferland, Louise Mallet (Canada)
Frequency and Determinants of Drug Administration Errors in the Intensive Care Unit of Two Dutch Hospitals [222]
Patricia MLA van den Bemt, Roel Fijn, Peter HJ van der Voort, Annet A Gossen, Toine CG Egbers, Jacobus RBJ Brouwers (The Netherlands)
Effect of the Time Latency between Beginning of Drug Use and Onset of Severe Cutaneous Adverse Reactions (SCAR) [223]
Maja Mockenhaupt, Juergen Schlingmann, Erwin Schoepf (Germany)
Medical Therapies for Lower Urinary Tract Symptoms and the Diagnosis of Prostate Cancer [225]
John W Logie, Richard DT Farmer (United Kingdom)
The IQOD Project: Organization, and Purposes [228]
Eric Van Ganse, Dorothy Keininger, IQOD Group (France)
Prevalence Estimation for Rare Neoplasms: [italic] Chronic Myeloid Leukemia[/italic] [229]
Lia P Gutierrez, Andrew Maguire (Spain)
Finasteride and Tamsulosin Used in Benign Prostatic Hypertrophy [232]
Ronald D Mann, Saad AW Shakir, Gillian L Pearce (United Kingdom)
Assessment of the Antimicrobial Capability of Three Denture Cleansers on an Hospitalized Geriatric Population [240]
Ana Miriam M Velly, Mervyn M Gornitsky, Isabelle I Paradis, German G Landaverde, Ana Maria M Malo (Canada)
Investigating Preventable Drug-Related Admissions to a Medical Admissions Unit [243]
Anthony J Avery, Rachel L Taylor, Malcolm Partridge, Karen Neil, Sarah Rodgers, Paul Howard, Judy Cantrill, Caroline Morris (United Kingdom)
Herbal Medicines to Pregnant and Lactating Women [264]
Gro C Havnen, Hedvig M Nordeng, Berit Smestad Paulsen (Norway)
Drug Wastage and Utilization: A Preliminary Community Based Pharmacoeconomic Study [266]
Faranak Ansari (Islamic Republic of Iran)
Estimating Public Health Impact of Adverse Drug Events in Pharmacoepidemiology: Phenylpropanolamine and Hemorrhagic Stroke [281]
Lois La Grenade, Parivash Nourjah, Robert L Sherman, Julie Beitz, Anne Trontell, David J Graham (United States)
A Pilot Survey of Knowledge Attitudes and Beliefs of Air Force Vaccine Providers Regarding the Anthrax Vaccine and Plans for a National Survey [282]
Debbie Gust, Lauren Jenks, Betsy Cadwell, Mike McNeil, Beth Hibbs (United States)
Impact of the Generosity Level of Supplemental Outpatient Prescription Drug Coverage on Prescription Expenditures and Events for Medicare Beneficiaries Age 65 Years and Older [285]
Margaret B Artz, Ronald S Hadsall, Stephen W Schondelmeyer (United States)
Lipid Screening in Kidney Transplant Patients within a Large Health Maintenance Organization [286]
Mark Alexander, Carlos G Iribarren, Juan Ordoñez, Elena Rivero, Cristina Varas, Alan S Go (United States, Spain)
The Prescription to Pediatric Inpatients of Unapproved and Off-Label Drugs [287]
Micheline MMdeA Meiners, Carlos CF Vidotti, Murilo F Dias, Gun B Bergsten-Mendes (Brazil)
Symptomatology in Cancer Patients: What's the Burden? [290]
Concetta Spoltore, Franca Goffredo, Oscar Bertetto, Marilena Romero (Italy)
Business Intelligence Tools for Signal Detection and Management of Pharmacovigilance [295]
Scott Stryker (United States)
Underuse of Generic Drugs in the Elderly: Evidence from Medicaid and Other Drug Insurance Programs [298]
Michael A Fischer, Jerry Avorn (United States)
Why Not Hold Pharmaceutical Companies Responsible for the Appropriate Use of Prescribed Medication? [299]
Regis Blais (Canada)
Safety and Effectivity of Tacalcitol in the Treatment of Psoriasis Vulgaris. The Spanish Experience [304]
M Lecha, Alfons Mirada, Juan Salvador López, Maite Artés (Spain)
Evaluation of Data Quality for Medication Monitoring and Intervention [305]
Anne M Holbrook, Karim Keshavjee, Jane P Kerby, Charles H Goldsmith, COMPETE Investigators (Canada)
Complementary and Alternative Medicine (CAM) Use by HIV Outpatients in Ontario, Canada: Patient Expenditures and Payment Methods [306]
Michelle D Furler, Thomas R Einarson, Reina Bendayan (Canada)
Patients' Profile among Overactive Bladder (OAB) Medication Users [311]
Sean Z Zhao, Matthew W Reynolds, John-Kenneth Billingsley, Scott C Henderson, Felix M Arellano (United States)
Rising Costs for Pharmaceuticals Largely Explained by Increased Intensity of Diagnosis and Early Start of Treatment [318]
Ron MC Herings, Martien JM Panneman, Ernst J de Graag, Hubert GM Leufkens (The Netherlands)
Impact of Leuteinizing Hormone Releasing Hormone Agonists on the Cytostatic Drug Market in Canada 1985-2000 [319]
Michael Iskedjian, Thomas R Einarson (Canada)
Epidemiological Study of Adverse Events in Accutane Users and Matched Non-Users: Retrospective Analysis of Major U.S. Health Plan Claims Database [329]
Maureen P Neary, Winslow Klaskala, John McLane, Susan P Ackermann (United States)
Collection of Adverse Events from Oncology Clinical Trials - What Value in Ongoing Safety Monitoring? [331]
Tharani Sivananthan, Andrzej Czarnecki, Valerie Simmons (United Kingdom)
Use of Herbals and Potential Interactions between Herbals and Conventional Drug Therapy in Older Adults Attending a Memory Clinic [338]
Monica SW Lee, Julie Dergal, Jennifer Gold, Dara Laxer, Krista Lanctot, Paula Rochon (Canada)
Patterns of Use of Natural Health Products among Ontario Seniors [345]
Kathryn Gaebel, Mitchell Levine, Nicole Brazier, Kevin Brazil, Lynn Lohfeld, Michel Bedard, Stuart MacLeod (Canada)
Potential Adverse Drug Interaction Classification to Select In-Patients for Drug Monitoring [347]
Murilo F Dias, Carlos CF Vidotti, Micheline MM de A Meiners, Gun B Bergsten-Mendes (Brazil)
The United Kingdom Paediatric Regional Monitoring Centre: Evaluation of the First Two Years [350]
J Bailey, A Clarkson, I ChoonaraI, K Cheng, P Arlett (United Kingdom)
The Progress of Brazilian Sanitation Legislation Relating to the Regulation on Medicine Advertisements [353]
Emília V Silva, Carlos CF Vidotti, Rogério Hoefler, Lidiane B Moraes, Lynn D Silver (Brazil)
Giving Feedback on Prescribing: Important Element in Quality Control of Drug Prescribing in Stockholm [368]
Ulf Bergman, Bjorn Wettermark (Sweden, Sweden)
Gemcitabine and Interaction with Anticoagulants [369]
Jean Kilgour-Christie, Andrzej Czarnecki (United Kingdom)
Evaluation of a Medication Supply System in a Community in Cuba [374]
Lilian Dyce Gordon, Maria Sanchez Rodriguez, Gladys Garcia Diaz, Migdalia Miranda Martinez (Cuba)
The Quality of Medications Use in the Elderly [376]
Johan Fastbom, Ingrid Schmidt, Amadou Jallow, Cecilia Bernsten (Sweden)
Funding and Managing Novel Multiple Sclerosis Drugs in Nova Scotia [379]
Murray G Brown, Jock Murray, Ingrid S Sketris, John D Fisk (Canada)

Last updated: 13 August, 2001